The Handoff: Your Week in Cardiology News - 1/27/17
The Handoff is a weekly roundup of cardiology news covering various developments in subspecialties, as well as pharmaceutical industry, association, and society news.
A soft robotic device restored blood flow after cardiac arrest in a porcine model, according to a new study published in Science Translational Medicine. While more research is necessary before human implantation, the researchers say the device could one day serve as a bridge to transplant.
In other “artificial intelligence” news, the SMARTChip biosensor may be able to detect the difference between a definite and a “possible” stroke, according to feature article published in The Guardian.
Electrocardiographs could be used as a means of data encryption for patients' Electronic Health Records. The idea was born when researchers from Binghamton University, State University of New York wanted to come up with a simple and cost-effective solution to protect personal health data.
According to a survey by Orlando Health, only 8% of women thought their heart screenings should start in their 20s and 60% thought screenings weren't recommended until after age 30.
Offering personalized risk information as well as a “taster” session at the National Health Service Stop Smoking Services more than doubled smokers' odds of quitting, according to a study published in The Lancet.
The American College of Cardiology has announced the late-breaking clinical trials for the ACC.17 meeting.
The US Preventive Services Task Force has issued a recommendation statement on screening for obstructive sleep apnea. Based on their review of the current evidence, the USPSTF concluded that more research is necessary to determine the benefits and harms of obstructive sleep apnea screening.
Companies around the country will support the American Heart Association's Life Is Why We Give fundraising campaign in February. They will also give customers the chance to donate in-store or online, and some will simply donate a percentage of the sale price to the AHA.